Table 5. Comparison of complication rates.
| Characteristicsa | Group P (n=29) | Group R (n=28) | χ 2b | P-value |
|
aEligible patients were randomized into either the "propofol group" (group P) or the "remimazolam group" (group R), and categorical data were expressed as n (%). bChi-square (χ2) tests (hypotension, injection pain), and continuity correction χ2 test (bradycardia, hypertension) were used to compare categorical data. **P < 0.001, compared with the group P.cBecause the frequency of tachycardia and hypoxemia in both groups was 0, no statistical analysis was performed. | ||||
| Hypotension | 8 (27.6) | 3 (10.7) | 2.604 | 0.107 |
| Bradycardia | 2 (6.9) | 3 (10.7) | 0.002 | 0.967 |
| Hypertension | 3 (10.3) | 5 (17.9) | 0.189 | 0.664 |
| Tachycardiac | 0 (0) | 0 (0) | – | – |
| Injection pain | 11 (37.9) | 0 (0) | 13.160 | < 0.001** |
| Hypoxemiac | 0 (0) | 0 (0) | – | – |